Tandem Diabetes Care Announces Upcoming Conference Participation and Presentations

Date : 08/29/2019 @ 8:30PM
Source : Business Wire
Stock : Tandem Diabetes Care Inc (TNDM)
Quote : 60.76  3.07 (5.32%) @ 5:00AM
After Hours
Last Trade
Last $ 61.00 ▲ 0.24 (0.39%)

Tandem Diabetes Care Announces Upcoming Conference Participation and Presentations

Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart

6 Months : From Jun 2019 to Dec 2019

Click Here for more Tandem Diabetes Care Charts.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will be attending the following upcoming investor conferences:

  • Baird Global Healthcare Conference on Wednesday, September 4, 2019 in New York City, including a presentation by Kim Blickenstaff, executive chairman, at 12:15pm Eastern Time (9:15am Pacific Time),
  • Dougherty & Company Institutional Investor Conference on Thursday, September 5, 2019 in Minneapolis,
  • Morgan Stanley Healthcare Conference on Wednesday, September 11, 2019 in New York City, including a presentation by John Sheridan, president and chief executive officer, at 10:30am Eastern Time (7:30am Pacific Time), and
  • Lake Street Best Ideas Growth Conference on Thursday, September 12, 2019 in New York City.

The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM. Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes. Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

Media Contact: Steve Sabicer 714-907-6264 ssabicer@thesabicergroup.com

Investor Contact: Susan Morrison 858-366-6900 x7005 IR@tandemdiabetes.com

Latest TNDM Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.